Get the Stockscreener App
5.16
0.58%
0.03
After Hours:
5.16
Lifecore Biomedical Inc stock is traded at $5.16, with a volume of 147.96K.
It is up +0.58% in the last 24 hours and up +34.38% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$5.13
Open:
$5.13
24h Volume:
147.96K
Relative Volume:
0.48
Market Cap:
$193.38M
Revenue:
$147.12M
Net Income/Loss:
$-33.88M
P/E Ratio:
-4.8574
EPS:
-1.0623
Net Cash Flow:
$2.63M
1W Performance:
+0.78%
1M Performance:
+34.38%
6M Performance:
-23.78%
1Y Performance:
-26.50%
1-Day Range:
$5.10
$5.37
1-Week Range:
$4.91
$5.37
52-Week Range:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, TEVA, HLN, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
5.16 | 192.26M | 147.12M | -33.88M | 2.63M | -1.0623 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
View All
Lifecore Biomedical Inc Stock (LFCR) Latest News
MSN Money - MSN
Before the bell May 6, Lifecore releases Q1 results, holds 8 a.m. webcast - Stock Titan
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN
[DEF 14A] LIFECORE BIOMEDICAL, INC. DE Definitive Proxy Statement - Stock Titan
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Lifecore hire gets 5,000 stock units that vest in 3 years - Stock Titan
Lifecore (NASDAQ: LFCR) executive RSU vesting leads to 24,645 shares withheld for tax - Stock Titan
The Technical Signals Behind (LFCR) That Institutions Follow - Stock Traders Daily
Will Lifecore Biomedical (LFCR) Stock Rise in 2026 | Price at $4.88, Up 2.74%Expert Verified Trades - Xã Châu Thành
Current Report Filing (8-k) - ADVFN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Form 8-KCurrent report - ADVFN
Form 4Statement of changes in beneficial ownership of securities - ADVFN
Form S-8Securities to be offered to employees in employee benefit plans - ADVFN
Form POS AMPost-Effective amendments for registration statement - ADVFN
Form DEF 14AOther definitive proxy statements - ADVFN
If You Invested $1,000 in Lifecore Biomedical Inc (LFCR) - Stock Titan
Lifecore Biomedical Receives 'Hold' Rating from Analysts - National Today
LFCR.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Death Cross: Is Lifecore Biomedical Inc on track to beat earningsEarnings Beat & Daily Profit Focused Screening - baoquankhu1.vn
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit - Sahm
Retail Surge: Is Lifecore Biomedical Inc trading at a discountWeekly Stock Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Inflation Data: Is Lifecore Biomedical Inc a strong candidate for buy and holdBear Alert & AI Enhanced Trading Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
2026-04-07 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | NDAQ:LFCR | Press Release - Stockhouse
Merger Talk: Is Lifecore Biomedical Inc forming bullish engulfing patterns2026 Pullbacks & Real-Time Buy Zone Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - GlobeNewswire Inc.
LFCR Should I Buy - Intellectia AI
LFCR PE Ratio & Valuation, Is LFCR Overvalued - Intellectia AI
LFCR Technical Analysis & Stock Price Forecast - Intellectia AI
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - Yahoo Finance
LFCR News & Events - Intellectia AI
Landec Corp. (US5147661046.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Transition period Earnings Call Transcript - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Momentum Shift: Can Lifecore Biomedical Inc continue delivering strong returns2026 Trade Ideas & Intraday High Probability Alerts - baoquankhu1.vn
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Buybacks Report: Is Lifecore Biomedical Inc a top pick in the sectorNew Guidance & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Claim your share of the $3.75M Lifecore Biomedical securities class action settlement - Claim Depot
Lifecore Biomedical Earnings Call Signals Profitable Shift - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):